Id |
Subject |
Object |
Predicate |
Lexical cue |
T35 |
2-13 |
DG_35 |
denotes |
Tocilizumab |
T10312 |
2-13 |
DG_35 |
denotes |
Tocilizumab |
T36 |
67-78 |
CL:0000080 |
denotes |
circulating |
T74668 |
67-78 |
CL:0000080 |
denotes |
circulating |
T37 |
79-90 |
CL:0000542 |
denotes |
lymphocytes |
T90672 |
79-90 |
CL:0000542 |
denotes |
lymphocytes |
T38 |
120-126 |
UBERON:0002405 |
denotes |
immune |
T2958 |
120-126 |
UBERON:0002405 |
denotes |
immune |
T39 |
127-140 |
GO:0065007 |
denotes |
dysregulation |
T86620 |
127-140 |
GO:0065007 |
denotes |
dysregulation |
T40 |
151-159 |
SP_7 |
denotes |
COVID-19 |
T3195 |
151-159 |
SP_7 |
denotes |
COVID-19 |
T41 |
180-184 |
PR:000001393 |
denotes |
IL-6 |
T88472 |
180-184 |
PR:000001393 |
denotes |
IL-6 |
T42 |
198-201 |
PR:000029150 |
denotes |
HLA |
T6458 |
198-201 |
PR:000029150 |
denotes |
HLA |